Omadacycline is a Potential New Drug For Treatment in Moderate to Severe Community-acquired Pneumonia. Issue 4 (July 2019)
- Record Type:
- Journal Article
- Title:
- Omadacycline is a Potential New Drug For Treatment in Moderate to Severe Community-acquired Pneumonia. Issue 4 (July 2019)
- Main Title:
- Omadacycline is a Potential New Drug For Treatment in Moderate to Severe Community-acquired Pneumonia
- Authors:
- Zappetti, Dana
- Abstract:
- Abstract : Synopsis: Omadacycline is a new antibiotic, derived from the tetracycline class, which might fill the need for a novel antibiotic that is effective against the common bacterial organisms causing community-acquired pneumonia. This trial showed it to be noninferior to moxifloxacin. Source: Stets R, Popescu M, Gonong JR, et al. Omadacycline for community-acquired bacterial pneumonia. N Engl J Med . 2019;380:517–527.
- Is Part Of:
- Clinical pulmonary medicine. Volume 26:Issue 4(2019)
- Journal:
- Clinical pulmonary medicine
- Issue:
- Volume 26:Issue 4(2019)
- Issue Display:
- Volume 26, Issue 4 (2019)
- Year:
- 2019
- Volume:
- 26
- Issue:
- 4
- Issue Sort Value:
- 2019-0026-0004-0000
- Page Start:
- Page End:
- Publication Date:
- 2019-07
- Subjects:
- Lungs -- Diseases -- Periodicals
616.24005 - Journal URLs:
- http://www.clinpulm.com ↗
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=toc&D=yrovft&AN=00045413-000000000-00000 ↗
http://journals.lww.com/clinpulm/pages/default.aspx ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/CPM.0000000000000316 ↗
- Languages:
- English
- ISSNs:
- 1068-0640
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.347000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 15043.xml